Home/Filings/4/0001437749-23-020210
4//SEC Filing

DARGAN CHARLES K 4

Accession 0001437749-23-020210

CIK 0000880242other

Filed

Jul 18, 8:00 PM ET

Accepted

Jul 19, 1:10 PM ET

Size

14.0 KB

Accession

0001437749-23-020210

Insider Transaction Report

Form 4
Period: 2023-07-17
DARGAN CHARLES K
Chief Financial Officer
Transactions
  • Award

    Option to purchase common stock

    2023-07-17+500,0004,189,893 total
    Exercise: $0.18From: 2023-07-17Exp: 2033-07-17Common stock (500,000 underlying)
Footnotes (2)
  • [F1]This Option was granted to Reporting Person to replace an option to purchase 300,000 shares that had been issued approximately 10 years ago to compensate Reporting Person for services to the Issuer and had expired unexercised due to a discrepancy between the original exercise price and current Issuer stock price, pursuant to plan adopted by the Issuer's Compensation Committee.
  • [F2]This total reflects the expiration of the option referenced in F1.

Issuer

BIOLARGO, INC.

CIK 0000880242

Entity typeother

Related Parties

1
  • filerCIK 0001112799

Filing Metadata

Form type
4
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 1:10 PM ET
Size
14.0 KB